Is there room for bevacizumab in metastatic breast cancer?
Lancet Oncol
.
2016 Sep;17(9):1175-6.
doi: 10.1016/S1470-2045(16)30295-9.
Epub 2016 Aug 5.
Author
Adam Brufsky
1
Affiliation
1
Department of Hematology-Oncology, University of Pittsburgh, Pittsburgh, PA 15213, USA. Electronic address: brufskyam@upmc.edu.
PMID:
27501769
DOI:
10.1016/S1470-2045(16)30295-9
No abstract available
Publication types
Comment
MeSH terms
Antibodies, Monoclonal, Humanized
Bevacizumab*
Breast Neoplasms*
Humans
Substances
Antibodies, Monoclonal, Humanized
Bevacizumab